Investor Relations

Basic information

Issuer Resaphene Suisse AG
Board of Directors Anke Rauterkus
Share capital 1,100.000 CHF
Number of shares 1,100.000 bearer shares at CHF 1
Year of foundation 2015
Accounting Local GAAP
Collective deposit SIX SIS AG, Baslerstrasse 100, CH-4601 Olten
Commercial Register Number CHE-425.422.997
FISN Resaphene Suis/BrSh CHF 1
ISIN CH0367465439
WKN A2JG91
LEI 8945000JP3FHX87LO121
VAT CHE-425.422.997
VALOR CH036746543
Paying Agent FinTech Group Bank AG, Rotfeder-Ring 7, D-60327 Frankfurt am Main

Financial Calendar

July 2021 General Assembly

Notices to Shareholders
Annual Meeting Protocol Resaphene

Sonja Dinnebier

"With tinniwell my tinnitus has almost completely disappeared. The combination of music and warmth is great, because it not only drowns out the noise, but the warmth in particular ensures relaxation and balance. "

Karin Baldauf

"The tinniwell is a great invention for people who suffer from tinnitus. For me more quality of life again. "

Werner Eisele

"I can recommend this holistic effective world first, to every tinnitus sufferer. Thank you again for the excellent and friendly service. "